Critics say this violates the principle of shareholder democracy and makes it harder for investors to hold boards to account.

There are at least 5 Israeli companies advancing human-centric care using AI of at least 1800 in biotechnology. Overseas ...

Aping the rhetoric of Elon Musk’s Department of Government Efficiency in the US, Labour’s Health Secretary Wes Streeting ...

Americans may end up paying more for their medicines as well as facing shortages of drugs they need. So it's possible there ...

A strong and efficient primary healthcare system — accessible, timely, and affordable — is one of the clearest indicators of a nation’s commitment to public health and well-being. Government ...

The approval of a new breast cancer treatment has given hope to thousands of women with an incurable form of the disease.

AstraZeneca is backing up its considerable investment in antibody-drug conjugates (ADCs) for cancer with the construction of a $1.5 billion new facility in Singapore to manufacture them.

AstraZeneca’s legal challenge to Medicare’s drug pricing negotiation powers has stumbled at the first hurdle in a federal court. US judge Colm Connolly of US district court in Delaware ...

China’s response to new United States (U.S.) tariffs could complicate the supply of important medicines, an analysis of data ...